Ichizo Nishino

Neurologist, Scientist

[Ichizo Nishino @one333]

We are excited to welcome all healthcare providers and researchers in the field of myology to Hiroshima for the 31st Annual Congress of the World Muscle Society, September 29 to October 3, 2026.
#WMS #WMS2026 #myology
https://t.co/kpZ2jBEvH6

[Ichizo Nishino @one333]

Our paper on sarcoidosis has been published! For the first time, we identified fusion transcripts between the retrotransposon "THE1B" and various canonical genes in sarcoid myopathy—without any structural changes in DNA. #sarcoidosis #retrotransposon
https://t.co/njsCAcTyJW

[Ichizo Nishino @one333]

この方は、下記のNatureの論文を読んでこう言っているのだろうか？

Robbeets M, et al. Triangulation supports agricultural spread of the Transeurasian languages. Nature. 2021 Nov;599(7886):616-621.

https://t.co/5BqpgLI88p @rekishijin_magより

[Ichizo Nishino @one333]

電撃チャレンジの開催は天候と #時間別の電力需要データ で決まっていると思う！＠OctopusenergyJPの #オクトパスチャレンジ に挑戦中🐙🔥

[Ichizo Nishino @one333]

Asian Oceanian Myology Center (#AOMC) and Japan Muscle Society (#JMS) will organize a joint annual congress AOMC-JMS 2024 (#AOMCJMS2024) in Nara, Japan on September 12-15, 2024. Save the date!

[Ichizo Nishino @one333]

@TLiewluck @WorldMuscleSoc Nice pictures!

[Ichizo Nishino @one333]

"Muscle pathology of antisynthetase syndrome according to antibody subtypes" was just published online. Full article can be downloaded for free.
https://t.co/cnQ9HRrFzQ
#ASS #myositis #musclepathology #antisynthetase

[Ichizo Nishino @one333]

Very much looking forward to!😍

[AOMC @AsianOceanianMy]

We are pleased to announce that the 21st Annual Meeting of the AOMC will be held on October 26-28, 2023 at Hotel Golden Tulip Shanghai Rainbow, Shanghai, China by the team led by Prof. Zhongbo Zhao (Shanghai) and Prof. Sophelia Hoi-Shan Chan (Hong Kong).
#aomc2023

[Neurology Journal @GreenJournal]

Dermatomyositis: Muscle Pathology According to Antibody Subtypes https://t.co/KBPiIkxFkV #Neurology #NeuroTwitter

[Ichizo Nishino @one333]

@LiquidTextCorp But only for the most expensive subscription plan?!😔

[JAMA Neurology @JAMANeuro]

Study suggests that OPDM_LRP12 is the most frequent OPDM subtype in Japan and is clinically characterized by predominant gastrocnemius and soleus muscle involvement in addition to oculopharyngeal weakness https://t.co/hOAdYqXOJ0

[Ichizo Nishino @one333]

Pathological features of anti-Mi-2 dermatomyositis https://t.co/9Vfr15zKdp

[Ichizo Nishino @one333]

Pathological features of anti-Mi-2 dermatomyositis https://t.co/irrewM7Yd5

[JAMA Neurology @JAMANeuro]

https://t.co/kWGK5r6kHa

[medRxiv @medrxivpreprint]

CGG expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy with neurological manifestations https://t.co/S6uxfVGlTa #medRxiv

[Ichizo Nishino @one333]

Although our idea may sound provocative, mounting papers indicate type 1 interferon plays a major role in damaging a variety of organs including skeletal muscle in COVID-19 - this mechanism is essentially the same as dermatomyositis.
#COVID19 #dermatomyositis #SARSCoV2

[Ichizo Nishino @one333]

"COVID-19-associated myositis may be dermatomyositis" has just been published online in Muscle & Nerve.
#COVID19 #dermatomyositis #SARSCoV2 #interferon

https://t.co/6QEZkwRg0Z

[Ichizo Nishino @one333]

"COVID-19-associated myositis may be dermatomyositis" has just been published online in Muscle & Nerve.
#COVID19 #dermatomyositis #SARSCoV2 #interferon

https://t.co/6QEZkwRg0Z

[Ichizo Nishino @one333]

これまで本当に存在するのかどうか議論のあった #Dermatomyositis sine dermatitisが確かに存在し、その多大部分の症例で抗NXP-2抗体が陽性であることが分かり、JAMA Neurologyにオンライン掲載されました。

[NCNP（国立精神・神経医療研究センター） @NCNP_PR]

[プレスリリース]皮疹（皮膚に生じる発疹）のない皮膚筋炎が存在することを証明し、それは自己抗体である抗NXP-2抗体と関連することを示しました。
https://t.co/e3SaJAhVtW
#NCNP

[NCNP（国立精神・神経医療研究センター） @NCNP_PR]

[プレスリリース]皮疹（皮膚に生じる発疹）のない皮膚筋炎が存在することを証明し、それは自己抗体である抗NXP-2抗体と関連することを示しました。
https://t.co/e3SaJAhVtW
#NCNP

[Ichizo Nishino @one333]

#Dermatomyositis sine dermatitis does exist and is associated with anti-NXP-2 autonatibodies.

[JAMA Neurology @JAMANeuro]

#Dermatomyositis sine dermatitis does exist! This cohort study also identified its strong association with anti-NXP-2 autoantibodies https://t.co/tpSn6IXLBu